Joseph Michael Fitzgerald
CIK 1484186 · EVP & Group Pres, Cardiology · last filed 2026-02-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
128
Lifetime Open-Market Net
-$78.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BSXw | EVP & Group Pres, Cardiology | 214,615 | — | — | -$78.51M | 128 | 2026-02-18 |
Recent Filings · Page 4 of 13
128 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-21 | BSXw | Tax (F) | −2,278 | -$107.7K | EDGAR |
| 2023-02-16 | BSXw | Mixed | +2,127 | -$117.7K | EDGAR |
| 2023-02-15 | BSXw | Mixed | −12,890 | $0 | EDGAR |
| 2023-01-03 | BSXw | Mixed | +6,476 | -$308.1K | EDGAR |
| 2022-12-14 | BSXw | Mixed | −1,000 | -$3.20M | EDGAR |
| 2022-03-07 | BSXw | Mixed | +1,824 | -$78.2K | EDGAR |
| 2022-02-24 | BSXw | Grant (A) | — | $0 | EDGAR |
| 2022-02-23 | BSXw | Mixed | +1,972 | -$81.8K | EDGAR |
| 2022-02-22 | BSXw | Mixed | +3,987 | -$165.9K | EDGAR |
| 2022-02-17 | BSXw | Mixed | +946 | -$100.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.